<DOC>
	<DOCNO>NCT02584010</DOCNO>
	<brief_summary>This study aim determine silicon-based gel silicon-based aerosol effective treatment postoperative scar .</brief_summary>
	<brief_title>Efficacy Study Two Silicon-based Products Treat Scars</brief_title>
	<detailed_description>Improve final aspect scar , challenge medicine . Silicon base product use various way prevent hypertrophic scar keloid since 1980 . A great percentage study show silicon-based product improve aspect scar different pathology . The main objective trial evaluate efficacy , use Vancouver scale , two silicon-based product ( Kelofin gel Kelofin aerosol ) 180 day . 300 participant meet inclusion criterion classify exclusion criterion randomly allocate one thre treatment group ( Kelofin Gel , Kelofin Aerosol treatment ) study .</detailed_description>
	<mesh_term>Silicon</mesh_term>
	<criteria>Fitzpatrick skin phototype I , II , III IV Participant recent surgical scar remodel phase ( 14 Â± 7 day surgery ) following : breast plastic inframammary incision ( fold beneath breast ) abdominoplasty , cesarean section , hysterectomy ( removal uterus ) , oophorectomy ( removal ovary ) , oophoroplasty ( removal nodule , cyst , etc . ovary ) , salpingectomy ( removal fallopian tube ) , tubal ligation , exploratory laparotomy ectopic pregnancy ( pregnancy outside uterus ) ( Pfannenstiel access road transverse incision , navel approximately one finger symphysis pubis ) . Skin Pathology product application area ; Diabetes ; Immune impairment ; Use systemic corticosteroid immunosuppressant ; Skin diseases : vitiligo , psoriasis , lupus , atopic dermatitis ; Background reaction siliconbased product ; Other illness medication may interfere directly study endanger health participant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Postoperative scar</keyword>
	<keyword>Cicatrix</keyword>
	<keyword>Cicatrization</keyword>
</DOC>